Published in Lancet on May 24, 1997
Is clinical breast examination an acceptable alternative to mammographic screening? BMJ (2000) 2.18
A "ladyplan" for trial recruitment?--Everyone's business! Lancet (1993) 1.66
Patient information materials in oncology: are they needed and do they work? Clin Oncol (R Coll Radiol) (1999) 1.56
U.K. DCIS Trial--time for review? Eur J Cancer (1993) 1.47
Consumers' views of quality in the consultation and their relevance to 'shared decision-making' approaches. Health Expect (2001) 1.42
Regulatory T cells expressing granzyme B play a critical role in controlling lung inflammation during acute viral infection. Mucosal Immunol (2012) 1.39
Clinical and molecular characterization of lipoid proteinosis in Namaqualand, South Africa. Br J Dermatol (2004) 1.32
Interventions to improve risk communication in clinical genetics: systematic review. Patient Educ Couns (2008) 1.31
Consequences of breast screening. Lancet (2000) 1.31
'Should a mammographic screening programme carry the warning: screening can damage your health!'? Br J Cancer (1999) 1.30
Information and involvement. Health Expect (2001) 1.19
Heterotransplantation of human glioblastoma multiforme and meningioma to nude mice. Proc Soc Exp Biol Med (1977) 1.17
Cells transformed by human Herpesvirus type 2 transcribe virus-specific RNA sequences shared by Herpesvirus types 1 and 2. Nat New Biol (1973) 1.10
Alliance between medical profession and consumers already exists in breast cancer. BMJ (1998) 1.09
Taeniasis and cysticercosis with special reference to Rhodesia. Cent Afr J Med (1969) 1.08
Breast cancer screening. Lancet (1998) 1.08
Written information for treating minor illness. Authors did not consider patients' view of information they received. BMJ (2001) 1.07
Clinical trials--a brave new partnership? J Med Ethics (1994) 1.02
Identification of adenovirus 12-encoded E1A tumor antigens synthesized in infected and transformed mammalian cells and in Escherichia coli. J Virol (1984) 1.01
Consumers and trials. Lancet (2001) 0.97
Conserved primary sequences of the DNA terminal proteins of five different human adenovirus groups. Proc Natl Acad Sci U S A (1979) 0.94
The voice of the breast cancer patient--a lonely cry in the wilderness. Eur J Cancer (1997) 0.93
Informed consent in medical research. We all have a responsibility to contribute to research. BMJ (1997) 0.92
Understanding "informed consent". Lancet (1995) 0.92
A survey of breast cancer patients' views on entry into several clinical studies. Eur J Cancer Care (Engl) (2004) 0.87
Can young severely disabled stroke patients regain the ability to walk independently more than three months post stroke? Clin Rehabil (2000) 0.86
Immunological and chemical identification of intracellular forms of adenovirus type 2 terminal protein. J Virol (1981) 0.85
Patients' preferences and randomised trials. Lancet (1994) 0.85
Tamoxifen for the prevention of breast cancer. Relationship of trial design to value of data for patient? Eur J Cancer (2000) 0.81
The effects of atropine and adrenergic antagonists on behavioral arousal in rats. J Gen Psychol (2000) 0.81
Virus-free adenocarcinoma of the frog (summer phase tumor) transcribes Lucké tumor herpesvirus-specific RNA. Science (1973) 0.80
Screening for breast cancer. Recommendations are costly and short sighted. BMJ (1995) 0.79
Survival after extended resection for locally advanced carcinomas of the colon and rectum. Ann R Coll Surg Engl (1984) 0.79
Proof of concept for a novel insecticide bioassay based on sugar feeding by adult Aedes aegypti (Stegomyia aegypti). Med Vet Entomol (2012) 0.78
Propranolol in hypotensive anaesthesia. Anaesthesia (1967) 0.76
Clinical trials, consensus conferences, and clinical practice. Lancet (1999) 0.75
Patients' understanding of clinical trials. Lancet (1998) 0.75
The cervical screening muddle. Lancet (1998) 0.75
Informed consent in clinical trials. ... of the principles of clinical trials. BMJ (1993) 0.75
Screening for breast cancer with mammography. Lancet (2002) 0.75
The screening debates: time for a broader approach? Eur J Cancer (2003) 0.75
Patients' preferences and randomised trials. Lancet (1996) 0.75
One and two view mammography in breast cancer. Many subjects in trial were not asked for consent. BMJ (1996) 0.75
Tracker trials. Continuous process of trial and review is needed. BMJ (2000) 0.75
Monitoring clinical trials. Caution may be warranted in releasing interim trial data. BMJ (2001) 0.75
Sentinel node biopsy in breast cancer. Effect on patients must be considered. BMJ (1999) 0.75
The marathon. Cent Afr J Med (1980) 0.75
Oncogenes in laryngeal cancer: serial passage of transformed cellular DNA. Otolaryngol Head Neck Surg (1985) 0.75
Studies on virus induction by 5-bromodeoxyuridine in nonproducer murine sarcoma virus-transformed 3T3 cells. Virology (1975) 0.75
A sacrifice for others? Ethical dilemmas surrounding the UK randomised trial for the management of screen-detected ductal carcinoma in situ of the breast. Prof Nurse (1993) 0.75
Rigor mortis of the heart as an indicator of pre-slaughter stress. Vet Rec (1971) 0.75
An ingenious method of destroying the vampire bats which transmit rabies to cattle. Cent Afr J Med (1980) 0.75
Population breast-cancer screening. Lancet (1995) 0.75
"Slaughter testicle" in the cryptorchid pig. Vet Rec (1972) 0.75
Give yourself a tapeworm? Vet Rec (1979) 0.75
Clinical trials in cancer: what makes for a successful study? Ann Oncol (2000) 0.75
A very controversial method of slaughter. Cent Afr J Med (1969) 0.75
The luck of the draw. Nurs Times (1992) 0.75
A symposium on hydatidosis. Cent Afr J Med (1980) 0.75
Oncogenes: preliminary studies in head and neck cancer. Laryngoscope (1983) 0.75
Making your meat safe. 7. On ascariasis, trichinosis, hydatid disease, cysticercosis and fascioliasis. Cent Afr J Med (1969) 0.75
Cellophane tape as an aid to the detection of Taenia saginata eggs. Cent Afr J Med (1973) 0.75
So-called scalding-water lungs in slaughtered pigs. Vet Rec (1974) 0.75
Socrates and the history of psychology. J Hist Behav Sci (1969) 0.75
The meat we eat. Cent Afr J Med (1977) 0.75
Making your meat safe. 6. Sarcocysts in the muscle of food animals. Cent Afr J Med (1967) 0.75
Making your meat safe. Cent Afr J Med (1966) 0.75
Hygromas in cattle. Cent Afr J Med (1970) 0.75
The public health danger of unsterilised pet foods. Vet Rec (1972) 0.75
Oncogenes: their presence and significance in squamous cell cancer of the head and neck. Laryngoscope (1985) 0.75
Solving the problem of contractures--throw out the recipe book? Physiother Res Int (1997) 0.75
Making your meat safe. Further information on hydatid disease in animals and man. Cent Afr J Med (1967) 0.75
A very controversial method of slaughter. Cent Afr J Med (1969) 0.75
Evidence-based information. Lancet (1999) 0.75
Foreign bodies in the organs of slaughtered animals. Vet Rec (1974) 0.75
Sarcosporidiosis-a review. Trop Anim Health Prod (1972) 0.75
Follow-up of postsecondary-age rural learning disabled graduates and dropouts. Except Child (1989) 0.75
Results and prognostic factors in salvage surgery for squamous carcinomas of the tongue. Br J Surg (1982) 0.75
The effects of menstruation and Microgynon 30 on sway behaviour. Agressologie (1978) 0.75
Making your meat safe. 3. Hydatid disease in Rhodesia. Cent Afr J Med (1967) 0.75
Improving paediatric diabetes care. Nurs Stand (2000) 0.75
Making your meat safe. 4. Further information on hydatid disease in animals and man. Cent Afr J Med (1967) 0.75